Home
About
Overview
Sharing Data
ORCID
Help
History (31)
Peripheral blood transcriptional profiling predicts tumor subtype and neoadjuvant chemoimmunotherapy outcomes in human breast cancer.
Longitudinal predictors of colorectal cancer screening among participants in a randomized controlled trial.
Survival analysis among unresectable pancreatic adenocarcinoma patients undergoing endoscopic or percutaneous interventions.
Race and Insurance Differences in the Receipt of Adjuvant Chemotherapy Among Patients With Stage III Colon Cancer.
Stage I Triple-Negative Breast Cancer: Moving From One-Size-Fits-All to a Personalized Approach.
See All 31 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Stage I Triple-Negative Breast Cancer: Moving From One-Size-Fits-All to a Personalized Approach.
Stage I Triple-Negative Breast Cancer: Moving From One-Size-Fits-All to a Personalized Approach. Am Soc Clin Oncol Educ Book. 2026 Jun; 46(3):e520666.
View in:
PubMed
subject areas
Biomarkers, Tumor
Female
Humans
Neoplasm Staging
Precision Medicine
Triple Negative Breast Neoplasms
authors with profiles
Rita Nanda